51 JFK Parkway, Short Hills, NJ 07078
Tuesday, November 3, 2026

Insights & Analysis

Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.

All articles

Page 1 of 110 · 995 articles
Reading Medicare CARC and RARC Codes in Audit Denials
Payor Disputes

Reading Medicare CARC and RARC Codes in Audit Denials

A Medicare remittance advice denial carries CARC and RARC codes that determine whether a claim needs a correction or a formal appe…

Anthony MahajanNov 2, 2026
Florida Board of Pharmacy Discipline for Pharmacists and Pharmacies
Healthcare Fraud Defense

Florida Board of Pharmacy Discipline for Pharmacists and Pharmacies

Florida Board of Pharmacy discipline runs from a signed complaint through a probable cause panel to an administrative complaint, t…

Anthony MahajanNov 2, 2026
PAMA Clinical Laboratory Fee Schedule Reporting and Audit Risk
Payor Disputes

PAMA Clinical Laboratory Fee Schedule Reporting and Audit Risk

PAMA requires many clinical laboratories to report private payor rates to CMS, and reporting errors carry civil penalties and audi…

Anthony MahajanNov 2, 2026
Hospital Peer Review Actions and Reports to the Licensing Board
Healthcare Fraud Defense

Hospital Peer Review Actions and Reports to the Licensing Board

How a hospital peer review action against a physician's privileges triggers an NPDB report and a board case, and how the fair hear…

Anthony MahajanNov 2, 2026
The In-Office Ancillary Services Exception Explained
Healthcare Fraud Defense

The In-Office Ancillary Services Exception Explained

The Stark Law exception that lets physicians bill in-house imaging and labs has three prongs, and failing one makes every referral…

Anthony MahajanNov 2, 2026
DEA Questions About Cash Payments and Distance Traveled
DEA Investigations

DEA Questions About Cash Payments and Distance Traveled

Why DEA treats cash payment and long-distance travel as red flags for controlled substance prescriptions, and how to document reso…

Anthony MahajanNov 2, 2026
DEA Registration for Med Spas and Wellness Clinics
DEA Investigations

DEA Registration for Med Spas and Wellness Clinics

Med spas and wellness clinics that administer Schedule III to V drugs may need their own DEA registration, with medical director l…

Anthony MahajanNov 2, 2026
DEA Inspections of Long-Term Care Facility Pharmacies
DEA Investigations

DEA Inspections of Long-Term Care Facility Pharmacies

DEA inspections of long-term care facility pharmacies focus on automated dispensing registration, Schedule II fax prescriptions, a…

Anthony MahajanNov 1, 2026
Florida Board of Medicine Probable Cause Panels and Administrative Complaints
Healthcare Fraud Defense

Florida Board of Medicine Probable Cause Panels and Administrative Complaints

How a Florida DOH complaint reaches a Board of Medicine probable cause panel, what an administrative complaint is, and the electio…

Anthony MahajanNov 1, 2026